0026-895X/09/7501-196–207$20.00MOLECULARPHARMACOLOGY
Copyright©2009TheAmericanSocietyforPharmacologyandExperimentalTherapeuticsMolPharmacol75:196–207,2009
Vol.75,No.149544/3419005PrintedinU.S.A.
FibroblastGrowthFactor(FGF)andFGFReceptor-MediatedAutocrineSignalinginNon–Small-CellLungCancerCells
LindsayMarek,KathrynE.Ware,AlexaFritzsche,PaulaHercule,WallaceR.Helton,JenniferE.Smith,LeeA.McDermott,ChristopherD.Coldren,RaphaelA.Nemenoff,DanielT.Merrick,BarbaraA.Helfrich,PaulA.Bunn,Jr.,andLynnE.Heasley
DepartmentsofCraniofacialBiology(L.M.,K.E.W.,A.F.,P.H.,J.E.S.,L.E.H.),Medicine(C.D.C.,R.A.N.,B.A.H.,P.A.B.),
Pharmacology(W.R.H.),andPathology(D.T.M.),UniversityofColoradoCancerCenter(C.D.C.,R.A.N.,B.A.H.,P.A.B.,L.E.H.),UniversityofColoradoatDenverAnschutzMedicalCampus,Aurora,Colorado;andHoffmann-LaRocheInc.,Nutley,NewJersey(L.A.M.)
ReceivedJune7,2008;acceptedOctober9,2008
ABSTRACT
Despitewidespreadexpressionofepidermalgrowthfactor(EGF)receptors(EGFRs)andEGFfamilyligandsinnon–small-celllungcancer(NSCLC),EGFR-specifictyrosinekinaseinhib-itors(TKIs)suchasgefitinibexhibitlimitedactivityinthiscan-cer.WeproposethatautocrinegrowthsignalingpathwaysdistinctfromEGFRareactiveinNSCLCcells.Tothisend,geneexpressionprofilingrevealedfrequentcoexpressionofspecificfibroblastgrowthfactors(FGFs)andFGFreceptors(FGFRs)inNSCLCcelllines.ItisnoteworthythatFGF2andFGF9aswellasFGFR1IIIcand/orFGFR2IIIcmRNAandproteinarefre-quentlycoexpressedinNSCLCcelllines,especiallythosethatareinsensitivetogefitinib.SpecificsilencingofFGF2reducedanchorage-independentgrowthoftwoindependentNSCLC
celllinesthatsecreteFGF2andcoexpressFGFR1IIIcand/orFGFR2IIIc.Moreover,aTKI[( )-1-(anti-3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido-[4,5-d]pyrimidin-2-one(RO4383596)]thattargetsFGFRsinhibitedbasalFRS2andextracellularsignal-regulatedkinasephosphorylation,twomeasuresofFGFRactivity,aswellasproliferationandanchorage-independentgrowthofNSCLCcelllinesthatcoexpressFGF2orFGF9andFGFRs.Bycontrast,RO4383596influencedneithersignaltransductionnorgrowthofNSCLCcelllineslackingFGF2,FGF9,FGFR1,orFGFR2expression.Thus,FGF2,FGF9andtheirrespectivehigh-affinityFGFRscompriseagrowthfactorautocrineloopthatisactiveinasubsetofgefitinib-insensitiveNSCLCcelllines.
Autocrinegrowthfactorproductionbycancercellsprovidesself-sufficiencyingrowthsignals,oneofthesixhallmarksofcancer(HanahanandWeinberg,2000).Basedonthefre-quentexpressionofEGFRinNSCLC(Hirschetal.,2003)aswellasthewidespreadcoexpressionwithvariousEGFfamilyligands(Ruschetal.,1997),theEGFRisanattractivecan-didateforareceptortyrosinekinasemediatingautocrine
ThestudiesweresupportedbyNationalInstitutesofHealthgrantsR01-CA116527,R01-CA127105,P30-CA046934,andP50-CA58187andaCancerLeagueofColoradogrant(toL.E.H.).
Article,publicationdate,andcitationinformationcanbefoundatdoc.guandang.net.
growthinNSCLC.Inthiscontext,theEGFRinhibitorsge-fitinibanderlotinibweredeployedinaseriesofclinicaltrialsbutyieldedresponseratesofonly10to20%(Dancey,2004;HirschandBunn,2005).Subsequentmolecularanalysisoftheresponsivelungtumorsrevealedasignificantenrichmentforgain-of-functionEGFRmutations(Lynchetal.,2004;Hanetal.,2005).ThegeneralinsensitivitytoEGFR-specificTKIsisalsoreflectedinculturedNSCLCcelllines(Coldrenetal.,2006;Helfrichetal.,2006).Thus,despitebroadexpressionofEGFRinNSCLC,onlyasubsetrespondstoEGFRinhibitors.WhereasraremutationsinEGFRthatrenderthetyrosinekinaseresistanttogefitinibanderlotinibhavebeenidenti-fied(Paoetal.,2005),thelimitedresponseofNSCLCto
ABBREVIATIONS:EGFR,epidermalgrowthfactorreceptor;EGF,epidermalgrowthfactor;TKI,tyrosinekinaseinhibitor;NSCLC,non–small-celllungcancer;FGF,fibroblastgrowthfactor;FGFR,fibroblastgrowthfactorreceptor;Ig,immunoglobulin;HITES,RPMI-1640containinghydro-cortisone/insulin/transferrin/estradiol/Na3SeO3/bovineserumalbumin;PCR,polymerasechainreaction;RT-PCR,real-timepolymerasechainreaction;RO4383596;( )-1-(anti-3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one;MTT,3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide;ELISA,enzyme-linkedimmunosorbentassay;ERK,extracellularsignalregu-latedkinase;PAGE,polyacrylamidegelelectrophoresis;VEGFR,vascularendothelialgrowthfactorreceptor;PDGFR,platelet-derivedgrowthfactorreceptor;GAPDH,glyceraldehyde-3-phosphatedehydrogenase;GFP,greenfluorescentprotein;VEGF,vascularendothelialgrowthfactor;IGF,insulin-likegrowthfactor;FRS2,FGFreceptorsubstrate2.196
IR的FGF保护_医药卫生_专业资料。Fibroblast growth factor-1 prevents ... on apoptosis assessed by terminal deoxynucleotidyl transferase-mediated dUTP ...
Inner M Abstract type and mechanism of fibroblast growth factor (FGF) were...new FGF receptor in the brain ,FGF21 in muscle ,and the use of ...
Evans1,6 Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine ...mitogenic activity and is mediated predominantly via FGF receptor 1 signalling...
TITLE FGF signaling is required for {beta}-catenin-mediated induction of ..." /go_function="fibroblast growth factor receptor binding; growth factor ...
expression of the fibroblast growth factor receptor and ligand genes in the...Localization of rat FGF -5 protein in skin macrophage-like cells and FGF-...
Fibroblast growth factor (FGF)-21 is a unique ...FGF/FGFR-mediated pathways may play important ...Klotho converts canonical FGF receptor into a ...
* SUMMARY Fibroblast growth factor (FGF) 9 is ...-catenin-mediated WNT signaling in a feed-...KEY WORDS: Lung, Branching, FGF, FGF receptor,...
fgf8 expression pattern is mediated by different ... positive regulation of Wnt receptor signaling ...product="fibroblast growth factor 8" /protein_id...
Inhibition of Fibroblast Growth Factor Receptor ...FGF-1 and FGF-2 are pleiotropic growth factors ... appear to be mediated by inhibition of FGFR-1...
fibroblast growth factor 23 null mice is a vitamin D - mediated process. ...FGF receptor into a specific receptor for FGF23. Nature, 2006, 444( 7120...
热门文档